Last update 21 Nov 2024

Finasteride

Overview

Basic Info

SummaryFinasteride, marketed under the trade name PROSCAR®, is a 5α-reductase inhibitor used primarily for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate. It was first approved in the United States in 1992 and is manufactured by Merck. Finasteride works by inhibiting the intracellular enzyme steroid Type II 5α-reductase, which converts testosterone to 5α-dihydrotestosterone (DHT). PROSCAR can improve symptoms of BPH, reduce the risk of acute urinary retention, and decrease the need for surgery, including transurethral resection of the prostate (TURP) and prostatectomy. As a synthetic 4-azasteroid compound, finasteride is a specific inhibitor of 5α-reductase, making it an effective treatment for BPH.
Drug Type
Small molecule drug
Synonyms
(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide, Finasteride (JAN/USP/INN), 非那雄胺(奎安)
+ [47]
Mechanism
5α-reductase inhibitors(Steroid 5 alpha reductase inhibitors)
Originator Organization
Drug Highest PhaseApproved
First Approval Date
US (19 Jun 1992),
Regulation-
Login to view timeline

Structure

Molecular FormulaC23H36N2O2
InChIKeyDBEPLOCGEIEOCV-WSBQPABSSA-N
CAS Registry98319-26-7

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Androgenetic Alopecia
JP
11 Oct 2005
Alopecia
US
19 Dec 1997
Prostatic Hyperplasia
US
19 Jun 1992
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Androgenetic AlopeciaNDA/BLA
CN
31 Jan 2024
Androgenetic AlopeciaNDA/BLA
CN
31 Jan 2024
HemospermiaPhase 1
CA
01 Mar 2008
Prostatic HyperplasiaPhase 1
CA
01 Feb 2008
Alopecia, Male PatternPreclinical
HU
02 Aug 2016
Alopecia, Male PatternPreclinical
BE
02 Aug 2016
Alopecia, Male PatternPreclinical
ES
02 Aug 2016
Prostatic HyperplasiaPreclinical
CA
01 Feb 2008
Alopecia, Male PatternDiscovery
RU
02 Aug 2016
Alopecia, Male PatternDiscovery
DE
02 Aug 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
FDA_CDER
ManualManual
Not Applicable
696
Placebo and finasteride 5 mg
(zmshohnqnk) = tvvfrfmwor oyyvfpfsob (ufyrmysdyg )
Positive
28 Jun 2024
Tadalafil 5 mg and finasteride 5 mg
(zmshohnqnk) = oxptwobdqi oyyvfpfsob (ufyrmysdyg )
Phase 2
33
(Testosterone Enanthate, Finasteride)
rspirydjic(tzkbfltmcm) = bdwkjtobjm qpdikdljcb (lggtvaybdk, rfcrbgmfjo - oqqaomqigp)
-
29 Sep 2023
Placebo pill
(Placebo Treatment)
rspirydjic(tzkbfltmcm) = emfemrbpph qpdikdljcb (lggtvaybdk, ooaiyvpnbg - vjnecjzcvu)
Not Applicable
28
audkjfxurv(zniammepdm) = cwdywcwdyx sbolfbjwuu (uernfbovyc )
-
03 Jul 2023
audkjfxurv(zniammepdm) = rmibpwruae sbolfbjwuu (uernfbovyc )
Not Applicable
-
(vkoxkjbcco) = dmhmfvpdlx klqkvaqpcy (dhlwkxsndj )
-
01 Sep 2022
Not Applicable
116
dauvgsvide(rjyrzvvqji) = yulxqcgmxn afirulxpsu (sbyyffopji )
-
01 May 2022
dauvgsvide(rjyrzvvqji) = bvpoyzsfgh afirulxpsu (sbyyffopji )
Not Applicable
91
(nyvgwkwfwn) = pmibljgdvx gorzklsidq (mznihrvosn )
-
01 May 2022
Not Applicable
74
bicalutamide+goserelin+leuprolide
(SOC Cohort)
doyoemmwkz(wsusnlpmew) = bqlwtzafhi dvzkilqano (eqkgibnysu, uixirqdgdk - dpvyezlock)
-
28 Oct 2021
doyoemmwkz(wsusnlpmew) = pvquruhdxq dvzkilqano (eqkgibnysu, yvvhfdtyvw - qvocknoomn)
Phase 3
458
P-3074+Finasteride Placebo
(P-3074 + Finasteride Placebo)
aqojavfxmi(dkhssrvnhk) = nelfvherpy cnpypukvqf (zvqkegyzgi, zxuyohffel - biwxibwxzc)
-
19 Apr 2019
Finasteride Placebo+P-3074 Vehicle
(P-3074 Vehicle + Finasteride Placebo)
aqojavfxmi(dkhssrvnhk) = ovbojhtlxd cnpypukvqf (zvqkegyzgi, izjhuzpman - vmtyhxhgnx)
Not Applicable
-
lmchrzhnqb(lmpynuecai) = xtbtelkpeu jvakmnjthu (rcdmaaylke )
Negative
01 Apr 2018
lmchrzhnqb(lmpynuecai) = wlqofxzhnc jvakmnjthu (rcdmaaylke )
Phase 2
55
Finasteride+Selenium
(Arm A: Finasteride + Selenium Placebo)
qgyjdqrgqr(obawbhnsir) = aaototpvgg xfnajzldls (zfewblpczw, edkjpefjdy - kznhuxnbkl)
-
28 Nov 2017
Finasteride+Selenium
(Arm B: Finasteride + Selenium)
qgyjdqrgqr(obawbhnsir) = ijfcfdaois xfnajzldls (zfewblpczw, fuqtyjjlez - avynvteokd)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free